H&R GmbH & Co. KGaA Reports Preliminary Q1 2026 Results

H&R GmbH & Co. KGaA announced its preliminary results for Q1 2026, revealing a slight decrease in sales revenue and EBITDA compared to the previous year. Operating profit stood at EUR 21.9 million, slightly below Q1 2025's EUR 22.4 million. Despite a 13.2% drop in sales revenue to EUR 300.2 million, the company showed improvement in earnings, with EBIT rising to EUR 9.5 million and net income reaching EUR 3.9 million, up from EUR 1.9 million in Q1 2025. Earnings per share improved, doubling to EUR 0.10.

The ChemPharm Refining segment performed well with a profit increase to EUR 14.6 million, but international operations under the ChemPharm SALES segment showed weaker results. The PLASTICS segment recorded a loss, impacting consolidated figures. However, cash flow improved significantly due to lower input costs.

Assets rose to EUR 943.4 million, while equity remained stable. The company maintains its full-year guidance for 2026, expecting earnings between EUR 85 million and EUR 100 million.